Ulviprubart (ABC-008) is a monoclonal antibody targeting the KLRG1 receptor that selectively depletes highly differentiated cytotoxic T cells. Ulviprubart can be used in the study of inclusion body myositis (IBM)[1].
Molecular Weight:
(146.96 kDa)
Purity:
99.68
CAS Number:
[2569434-60-0]
Target:
C-type Lectin-like Receptors (CTLRs)
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
